Literature DB >> 29026626

Acute diarrhoea due to a Shiga toxin 2e-producing Escherichia coli O8 : H19.

Angela Saupe1, Birgit Edel1, Wolfgang Pfister1, Bettina Löffler1, Ralf Ehricht2, Jürgen Rödel1.   

Abstract

Introduction. Identification of non-O157 Shiga-toxin-producing Escherichia coli (STEC) infections may be underestimated in microbiological diagnosis. Case presentation. A 58-year-old woman developed diarrhoea with watery and subsequently mucous stool. Initial multiplex PCR testing revealed a positive result for stx2 . Culture isolation of a STEC was successful only after repeated inoculation of chromogenic E. coli media. Molecular characterization was performed and identified the isolate as stx2e-positive STEC of serotype O8 : H19. The strain harboured lpfA, but not eae. Conclusion. This case highlights the usefulness of initial multiplex PCR for diagnosis of non-O157 STEC infection.

Entities:  

Keywords:  STEC infection; antibiotics; azithromycin; diarrhoea

Year:  2017        PMID: 29026626      PMCID: PMC5630968          DOI: 10.1099/jmmcr.0.005099

Source DB:  PubMed          Journal:  JMM Case Rep        ISSN: 2053-3721


Abbreviations

EHEC, enterohaemorrhagic Escherichia coli; LP, long polar; STEC, Shiga-toxin-producing Escherichia coli.

Introduction

Shiga-toxin-producing Escherichia coli (STEC) are important food-borne enteric pathogens. There are several Shiga-toxin (Stx) variants that have been associated with various clinical manifestations; in particular, strains with the combined presence of stx 2 and eae (intimin) genes are often responsible for severe outcomes, such as haemorrhagic colitis and haemolytic uraemic syndrome [1]. The major pathogen of this group belongs to the serotype O157. There is a growing number of non-O157 STEC in humans that have been isolated from patients in clinical cases and from outbreaks [2-5]. Because non-O157 STEC can possess uncommon serotypes and are often not distinguishable from non-pathogenic E. coli on selective and chromogenic media, they are difficult to isolate and remain under-recognized in the laboratory. In this report, we present a symptomatic case caused by a stx 2e-expressing STEC of serotype O8 : H19 that would not have been diagnosed without pre-screening of the stool sample with multiplex PCR.

Case report

In early summer of 2016, a 58-year-old woman experienced watery diarrhoea and vomiting. The patient had spent a weekend with her family in the north of Germany. Two days before disease onset, she had eaten poultry liver for lunch and grilled swine meat at an evening barbecue. Other family members also consumed the swine meat, but did not develop any symptoms. The patient's medical history was significant for diabetes mellitus, but no other risk factors. A mild diet led to recovery after 2 days. After shifting to a normal diet, she felt sick again with developing watery diarrhoea. Replacement of diet and symptomatic treatment did not lead to any improvement, and during the next few days she produced mucous stool and suffered from abdominal pain, tenesmus and fatigue. After 1 week of disease, the patient visited a medical practitioner and a stool sample was analysed in the laboratory. An initial rapid test using the Verigene EP assay (Luminex, purchased from Thermo Fisher) showed a positive result for stx. The test was negative for stx, Salmonella spp., Shigella spp., Campylobacter spp., Yersinia enterocolitica, Vibrio spp., norovirus and rotavirus.Clostridiumdifficile tested negative by single PCR (BD Max; BD). For culture, the stool sample was streaked onto Salmonella– Shigella-agar, Hektoen agar, Butzler agar, CIN agar and Brilliance E. coli/coliform chromogenic agar (all plates were purchased from Oxoid, Thermo Fisher Scientific). For enrichment of pathogenic bacteria, Gram-negative (GN) broth and selenite broth (BD) were inoculated. On one hand, culture confirmed the negative results of the Verigene assay; on the other hand, E. coli colonies isolated on chromogenic agar did not agglutinate with polyspecific antibody reagents directed against frequent serotypes (Sifin Diagnostics) and tested negative for stx 2 using the RIDAGENE EHEC/EPEC real time multiplex PCR (R-Biopharm). Agglutination and PCR were also performed from the inoculum site using a mixture of colonies. Brilliance E. coli/coliform agar was inoculated again with stool and GN broth samples, and on the following day testing of colonies for stx 2 by PCR was positive for the original stool specimen and GN broth. stx 1 and eae genes were not detected. Agglutination with polyclonal antisera covering 22 O serotypes (O25, O26, O44, O55, O78, O86, O91, O103, O111, O114, O118, O119, O124, O125, O126, O127, O128, O142, O145, O157, O158 and O164) also remained negative. Species identification was performed by MALDI-TOF MS (Vitek-MS) and biochemistry (Vitek-2). The strain was positive for β-galactosidase, β-glucuronidase and sorbitol fermentation. The patient was treated with azithromycin (500 mg day−1) for 3 days and recovered after 2 days without any relapse.

Investigations

To identify the unusual serotype and additional virulence factors, the STEC isolate was characterized using the E. coli PanType AS2 genotyping kit (Alere Technologies). This hybridization array includes several hundred sets of oligonucleotides for DNA-based detection of virulence and resistance genes, and it covers genes for the identification of 23 epidemiologically relevant O-antigens, as well as 47 H-antigens. The Shiga toxin was identified as stx 2e, which is rarely observed among human isolates [2, 6]. Serotypes O8 and H19 were identified. The strain was negative for eae and type III secretion system (T3SS) genes, but positive for lpfA, encoding long-polar (LP) fimbriae that are associated with diarrhoeagenic strains of E. coli [7, 8]. Three resistance genes were detected: strB, encoding aminoglycoside-6′′-phosphotransferase; tetA, encoding tetracycline efflux protein; and bla TEM, encoding a β-lactamase. Phenotypic resistance was found against ampicillin and piperacillin.

Discussion

This case describes the rare isolation of a stx 2e-producing E. coli from a patient with acute diarrhoea and vomiting. Only about 1 % of STEC infections in humans have been attributed to stx 2e [9]. Pigs are known to carry stx 2e-positive E. coli causing oedema disease. The isolated E. coli strain belonged to a group of eae-negative STEC that express stx 2 and alternative adhesins such as LP fimbriae. LP fimbriae have been described in STEC/enterohaemorrhagic E. coli (EHEC) and enteropathogenic E. coli (EPEC), and they are also present in O157 : H7 strains. The isolate was of serotype O8 : H19. Unusual serotypes may not be covered by the commercial polyclonal antisera used for standard diagnosis of human infections. Therefore, screening of colonies in cultures should be performed by stx PCR. Serotype O8 : H19 is characteristic for porcine stx 2e-producing E. coli, so pork meat may have been the source of infection in the present case [6, 10]. The patient was treated with azithromycin because of recurrence of diarrhoea and impairment after stopping a mild diet. Azithromycin was successfully applied in patients with EHEC infections during the German O104 EHEC outbreak and has been shown to reduce the time of shedding bacteria [11]. The patient benefited from the azithromycin therapy rapidly. This case of STEC infection would not have been diagnosed without an initial culture-independent PCR multiplex assay. Low levels of STEC in stool samples may be responsible for the failure to isolate such strains in culture. The STEC was isolated only after repeated inoculation of E. coli/coliform chromogenic media. Because the strain was positive for β-galactosidase, β-glucuronidase and sorbitol fermentation, its colonies could not be distinguished morphologically from E. coli background flora. Therefore, this case highlights the usefulness of a culture-independent rapid molecular test that provides a diagnostic result without significant time delay. The Verigene EP microarray test used in our laboratory is an U.S. Food and Drug Administration (FDA)-cleared microarray test with automated processing. The test running time is about 2.5 h, with less than 5 min of hands-on time, including sample preparation. The implementation of such tests for routine stool diagnostics depends on the costs for machines and consumables. These factors may limit the general use for all samples, but the implementation for cases with the need of sensitive and rapid diagnosis is an important option for the clinical microbiology laboratory [12, 13]. In 2016, we performed 34 tests in cases of acute diarrhoea with 12 positive results. In four cases, no isolate could be obtained from culture, including for one case of STEC (Table 1). Multiplex PCR assays for diarrhoeagenic bacteria may not only be used as rapid screening tools but also be reasonable tests in cases with negative culture and virus PCR despite acute diarrhoea.
Table 1.

Comparison of Verigene EP and culture results

Culture positiveCulture negative
Verigene EP positive8*4†
Verigene EP negative022

* Salmonella spp. (5), Campylobacter spp. (2), STEC (1).

† Salmonella spp. (1), Shigella spp. (1), Campylobacter spp. (1), STEC (1).

* Salmonella spp. (5), Campylobacter spp. (2), STEC (1). † Salmonella spp. (1), Shigella spp. (1), Campylobacter spp. (1), STEC (1).
  13 in total

1.  Performance of the Verigene® enteric pathogens test, Biofire FilmArray™ gastrointestinal panel and Luminex xTAG® gastrointestinal pathogen panel for detection of common enteric pathogens.

Authors:  Richard S P Huang; Coreen L Johnson; Lauryn Pritchard; Richard Hepler; Trang T Ton; James J Dunn
Journal:  Diagn Microbiol Infect Dis       Date:  2016-09-22       Impact factor: 2.803

2.  Hemolytic uremic syndrome in a 65-Year-old male linked to a very unusual type of stx2e- and eae-harboring O51:H49 shiga toxin-producing Escherichia coli.

Authors:  Dominique Fasel; Alexander Mellmann; Nicole Cernela; Herbert Hächler; Angelika Fruth; Nina Khanna; Adrian Egli; Christiane Beckmann; Hans H Hirsch; Daniel Goldenberger; Roger Stephan
Journal:  J Clin Microbiol       Date:  2014-02-05       Impact factor: 5.948

3.  Identification of virulence genes linked with diarrhea due to atypical enteropathogenic Escherichia coli by DNA microarray analysis and PCR.

Authors:  Jan Egil Afset; Guillaume Bruant; Roland Brousseau; Josée Harel; Endre Anderssen; Lars Bevanger; Kåre Bergh
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

Review 4.  Molecular epidemiological view on Shiga toxin-producing Escherichia coli causing human disease in Germany: Diversity, prevalence, and outbreaks.

Authors:  Angelika Fruth; Rita Prager; Erhard Tietze; Wolfgang Rabsch; Antje Flieger
Journal:  Int J Med Microbiol       Date:  2015-08-21       Impact factor: 3.473

5.  Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4.

Authors:  Martin Nitschke; Friedhelm Sayk; Christoph Härtel; Rahel Tabea Roseland; Susanne Hauswaldt; Jürgen Steinhoff; Klaus Fellermann; Inge Derad; Peter Wellhöner; Jürgen Büning; Bettina Tiemer; Alexander Katalinic; Jan Rupp; Hendrik Lehnert; Werner Solbach; Johannes K-M Knobloch
Journal:  JAMA       Date:  2012-03-14       Impact factor: 56.272

6.  Prevalence and characteristics of Shiga toxin-producing Escherichia coli isolated from retail raw meats in China.

Authors:  Xiangning Bai; Hong Wang; Youquan Xin; Rongjie Wei; Xinyuan Tang; Ailan Zhao; Hui Sun; Wang Zhang; Yan Wang; Yanmei Xu; Zhengdong Zhang; Qun Li; Jianguo Xu; Yanwen Xiong
Journal:  Int J Food Microbiol       Date:  2015-01-30       Impact factor: 5.277

7.  Evaluation of the BioFire FilmArray® GastrointestinalPanel in a Midwestern Academic Hospital.

Authors:  C N Murphy; R C Fowler; P C Iwen; P D Fey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-12       Impact factor: 3.267

8.  Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology.

Authors:  Alexander Mellmann; Dag Harmsen; Craig A Cummings; Emily B Zentz; Shana R Leopold; Alain Rico; Karola Prior; Rafael Szczepanowski; Yongmei Ji; Wenlan Zhang; Stephen F McLaughlin; John K Henkhaus; Benjamin Leopold; Martina Bielaszewska; Rita Prager; Pius M Brzoska; Richard L Moore; Simone Guenther; Jonathan M Rothberg; Helge Karch
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

9.  Shiga toxin-producing Escherichia coli serotype O78:H(-) in family, Finland, 2009.

Authors:  Taru Lienemann; Eeva Salo; Ruska Rimhanen-Finne; Kai Rönnholm; Mari Taimisto; Jari J Hirvonen; Eveliina Tarkka; Markku Kuusi; Anja Siitonen
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 6.883

Review 10.  Role of Verocytotoxigenic Escherichia Coli in the Swine Production Chain.

Authors:  Laura Ercoli; Silvana Farneti; David Ranucci; Stefania Scuota; Raffaella Branciari
Journal:  Ital J Food Saf       Date:  2015-06-29
View more
  6 in total

1.  Seasonal Prevalence of Shiga Toxin-Producing Escherichia coli on Pork Carcasses for Three Steps of the Harvest Process at Two Commercial Processing Plants in the United States.

Authors:  Ivan Nastasijevic; John W Schmidt; Marija Boskovic; Milica Glisic; Norasak Kalchayanand; Steven D Shackelford; Tommy L Wheeler; Mohammad Koohmaraie; Joseph M Bosilevac
Journal:  Appl Environ Microbiol       Date:  2020-12-17       Impact factor: 4.792

2.  Implications of stx loss for clinical diagnostics of Shiga toxin-producing Escherichia coli.

Authors:  Thulasika Senthakumaran; Lin Torstensen Brandal; Bjørn-Arne Lindstedt; Silje Bakken Jørgensen; Colin Charnock; Hege Smith Tunsjø
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-28       Impact factor: 3.267

3.  Rapid culture-based identification of Shiga toxin-producing Escherichia coli and Shigella spp./Enteroinvasive E. coli using the eazyplex® EHEC complete assay.

Authors:  Anika Penzel; Katrin Schützler; Jana Dröge; Alexander Mellmann; Ralf Ehricht; Ines Engelmann; Sascha D Braun; Benjamin T Schleenvoigt; Bettina Löffler; Jürgen Rödel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-09-16       Impact factor: 3.267

4.  Molecular Characterization and Comparative Genomics of Clinical Hybrid Shiga Toxin-Producing and Enterotoxigenic Escherichia coli (STEC/ETEC) Strains in Sweden.

Authors:  Xiangning Bai; Ji Zhang; Anoop Ambikan; Cecilia Jernberg; Ralf Ehricht; Flemming Scheutz; Yanwen Xiong; Andreas Matussek
Journal:  Sci Rep       Date:  2019-04-04       Impact factor: 4.379

5.  Virulence Profiling and Molecular Typing of Shiga Toxin-Producing E. coli (STEC) from Human Sources in Brazil.

Authors:  Adriene Maria Ferreira Cavalcanti; Rodrigo Tavanelli Hernandes; Elizabeth Harummyy Takagi; Beatriz Ernestina Cabílio Guth; Érica de Lima Ori; Sandra Regina Schicariol Pinheiro; Tânia Sueli de Andrade; Samara Louzada Oliveira; Maria Cecilia Cergole-Novella; Gabriela Rodrigues Francisco; Luís Fernando Dos Santos
Journal:  Microorganisms       Date:  2020-01-25

6.  Genomic Characteristics of Stx2e-Producing Escherichia coli Strains Derived from Humans, Animals, and Meats.

Authors:  Xi Yang; Yannong Wu; Qian Liu; Hui Sun; Ming Luo; Yanwen Xiong; Andreas Matussek; Bin Hu; Xiangning Bai
Journal:  Pathogens       Date:  2021-11-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.